Some explanations for this underutilization docs on access, patient knowledge, and motivation, but these fail to explain patterns observed across diverse populations
These treatment options should be used as appropriate for each person to decrease weight and optimize health.7 In this guideline, we update the pharmacotherapy recommendations in the 2020 Canadian clinical practice guideline on obesity in adults7 , 8 and the 2022 pharmacotherapy for obesity management revision,9 reviewing the literature pertaining to the efficacy and safety of obesity medications currently approved by Health Canada
The drugs, typically taken once weekly as injections, work by helping the pancreas increase the production of insulin to move sugar from the blood into body tissues
NO is a vasodilator, which helps deliver nutrients to muscle cells faster
After the success of many of these trials, the FDA commissioned additional labels specifically evaluating CVD risk reduction for empagliflozin, canagliflozin, and liraglutide
Unsupervised Cosmetic Use (CRITICAL WARNING): Its use as an unsupervised cosmetic tanning agent is highly discouraged by health authorities (FDA, TGA, HPRA) due to the unknown long-term risk of melanocytic proliferation and the development of new or atypical moles